Wikidata

(Q53531233)

English

Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell lines.

scientific article published in August 2007

In more languages

Statements

title
Schedule-dependent interaction between the proteosome inhibitor bortezomib and the EGFR-TK inhibitor erlotinib in human non-small cell lung cancer cell lines. (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
17762337
retrieved
15 May 2018
reference URL
http://europepmc.org/abstract/MED/17762337

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q53531233&oldid=947824410"